| Literature DB >> 29884474 |
Robin Loesch1, Christèle Desbois-Mouthon2, Sabine Colnot3.
Abstract
The CRISPR technology is rapidly transforming the field of liver research by its versatility and easy use. In vivo gene editing of hepatocytes in adult mice can be achieved using a broad toolbox for both fundamental research and development of therapeutic strategies for future clinical applications. Recent studies showed that CRISPR has a real potential to treat hereditary liver diseases as well as virally induced pathologies. This short review recapitulates very recent advancements regarding the use of CRISPR in liver research and therapy.Entities:
Keywords: CRISPR; In vivo; Liver; Research; Therapy
Mesh:
Year: 2018 PMID: 29884474 DOI: 10.1016/j.clinre.2018.05.001
Source DB: PubMed Journal: Clin Res Hepatol Gastroenterol ISSN: 2210-7401 Impact factor: 2.947